butofilolol has been researched along with Kidney Failure, Chronic in 1 studies
*Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cautreels, W; Giudicelli, CP; Houin, G; Jeanniot, JP; Ledudal, P; Tillement, JP | 1 |
1 other study(ies) available for butofilolol and Kidney Failure, Chronic
| Article | Year |
|---|---|
Butofilolol pharmacokinetics in chronic renal insufficiency.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Creatinine; Female; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Propanolamines | 1984 |